Sugary foods and drinks increase blood pressure

IN BRIEF

• High consumption of beverages and foods with added sugars is associated, in observational literature, with higher blood pressure levels and a greater incidence of hypertension.
• Many meta-analyses show a dose-response relationship: more daily servings of sugary drinks, greater the observed risk.
• Part of the association may be mediated by weight gain, metabolic alterations, and fructose-related mechanisms (e.g., uric acid), but evidence of direct causality remains limited.
• Observational studies also indicate possible renal effects and an association with cardiovascular risks; however, methodological limitations require cautious interpretation.
• For individuals, evidence supports moderate reduction of added sugars as a public health strategy; clinical decisions should be made with healthcare professionals.

Abstract: what does science say?

Beverages and foods with added sugars have been studied for over a decade in relation to obesity, diabetes, and cardiovascular diseases. For blood pressure, epidemiological literature shows a consistent correlation between higher consumption of sugary drinks and higher blood pressure levels or a greater incidence of hypertension. Several reviews and meta-analyses, based predominantly on observational studies and some short experimental studies, indicate a dose relationship (more servings per day → greater risk). Plausible mechanisms include weight gain, increased uric acid linked to fructose, metabolic effects on insulin and lipids, and behavioral factors related to lifestyle. However, the evidence does not automatically prove direct causality; the heterogeneity of studies, self-reported dietary measures, and possible confounding factors limit definitive conclusions. In summary: there is consistency between observational studies and meta-analyses on an association between added sugars (especially beverages) and increased blood pressure, but the estimation of the actual effect and its dependence on context, dose, and population require further research.

Main section: what studies have found and how to interpret the results

A systematic review published by the team led by Aaqib Habib Malik collected observational studies evaluating the link between sugary drink consumption and blood pressure; the authors observed a correlation between higher consumption and higher blood pressure values and emphasized the importance of including consumption limitations in public health recommendations [1].

Subsequent meta-analyses and independent systematic reviews have confirmed this trend: a quantitative synthesis of prospective cohorts estimated a relative increase in the risk of hypertension for each additional daily serving of sugary drink. For example, a systematic review and meta-analysis of prospective cohorts highlighted a percentage increase in the risk of hypertension associated with increased intake of sugary drinks [2]. A dose-response analysis reported similar results, suggesting that the effect increases with consumption frequency [3].

Not all analyses are identical: some reviews that also considered artificially sweetened beverages have seen risk signals for "light" versions as well, but the results are less consistent and subject to confounding from health-related behaviors [4][5]. Observational evidence is numerous and often consistent in the general pattern (positive association), but it has intrinsic limitations that affect the degree of confidence in the results (see Limitations section).

In addition to the association with blood pressure, large studies have correlated high added sugar intake with increased cardiovascular mortality and other metabolic outcomes, strengthening the overall risk picture linked to excess sugars in the diet [6]. Finally, some epidemiological research has highlighted possible renal repercussions associated with high consumption of sweetened beverages, including associations with albuminuria and decline in kidney function in specific cohorts of women [7].

Overall, the literature suggests consistency and biological plausibility, but the need remains to distinguish association from direct causality and to consider the role of body weight, dietary patterns, and other cardiovascular risk factors.

What it means in practice

For the general public, the summarized results indicate that frequent consumption of beverages and foods with added sugars is correlated with a higher observed risk of elevated blood pressure and hypertension in the long term. This does not imply that a single drink immediately causes hypertension, but that repeated and prolonged consumption habits over time are associated with a greater risk at the population level [2][3].

From a public health perspective, interventions aimed at reducing added sugar intake in beverages are considered valid measures to combat cardiometabolic risk factors on a large scale; several health authorities include recommendations to limit sugary drinks as part of an overall healthy eating plan [1][5].

For an individual, the practical translation depends on the context: frequency of consumption, quantity, body weight, baseline blood pressure, and presence of other risk factors. Even moderate reductions in sugary drink consumption contribute to lower caloric intake and can help prevent weight gain, one of the known mediators of blood pressure risk [3][6]. For personalized clinical choices, it is advisable to consult a doctor or nutritionist.

Key points to remember

The main evidence emerging from the literature can be summarized in the following points:

• There is a consistent association between high consumption of sugary drinks and higher blood pressure levels observed in large-scale cross-sectional and prospective studies [1][2].
• Dose-response meta-analyses report an increased risk of hypertension for each additional daily serving of sugary drink, suggesting a quantity-dependent effect [3].
• Part of the effect may be mediated by weight gain and metabolic mechanisms related to fructose (e.g., increased uric acid), but direct causality evidence remains incomplete [6].
• Some studies suggest potential negative effects even for artificially sweetened beverages, but the results are less homogeneous and may reflect confounding factors [4][5].
• Public health recommendations suggesting limiting sugary drinks are based on the totality of evidence related to obesity, diabetes, cardiovascular diseases, and blood pressure [6].

Limitations of the evidence

It is essential to interpret observations with caution. Most of the evidence comes from observational studies that can show associations but not prove causality. Key limitations include self-reported dietary measurements subject to error, variations in the definition of hypertension across studies, incomplete adjustments for confounders (e.g., physical activity, overall diet, salt intake), and the possible mediating effect of body weight.

Methodological heterogeneity among studies (different populations, duration, type of beverages considered) complicates the precise quantification of risk. Controlled experimental studies directly evaluating the long-term effect of sugary drinks on blood pressure are few; many interventions are short and do not always replicate real consumption habits. Finally, the presence of signals on artificially sweetened beverages requires further investigation to separate direct effects from selection factors or compensatory behavior.

Editorial conclusion

Consolidated evidence indicates that, at the population level, frequent and abundant consumption of beverages and foods with added sugars is associated with an increase in blood pressure values and a higher incidence of hypertension. This association is supported by several meta-analyses and prospective cohorts, but the observational nature of the studies limits the assertion of a certain cause-and-effect relationship. From a practical point of view, reducing added sugar intake is a plausible strategy consistent with guidelines for the prevention of cardiometabolic diseases; however, individual decisions must be made with the support of healthcare professionals who contextualize risks and benefits.

SCIENTIFIC RESEARCH

Below are the primary sources and reviews cited in the text. DOIs are verified and provided for transparency and control.

1. Malik AH, Akram Y, Shetty S, Malik SS, Yanchou Njike V. Impact of Sugar-Sweetened Beverages on Blood Pressure. The American Journal of Cardiology. 2014;113(9):1574–1580. https://doi.org/10.1016/j.amjcard.2014.01.437
2. Jayalath VH, de Souza RJ, Ha V, et al. Sugar-sweetened beverage consumption and incident hypertension: a systematic review and meta-analysis of prospective cohorts. The American Journal of Clinical Nutrition. 2015;102(4):914–921. https://doi.org/10.3945/ajcn.115.107243
3. Xi B, Huang Y, Reilly KH, et al. Sugar-sweetened beverages and risk of hypertension and cardiovascular disease: a dose–response meta-analysis. British Journal of Nutrition. 2015;113(5):709–717. https://doi.org/10.1017/S0007114514004383
4. Clinical and Experimental Hypertension. Sugar and artificially sweetened soda consumption linked to hypertension: A systematic review and meta-analysis. 2015;37(7). https://doi.org/10.3109/10641963.2015.1026044
5. Frontiers in Nutrition. Consumption of sugar-sweetened beverages, artificially sweetened beverages and fruit juices and risk of type 2 diabetes, hypertension, cardiovascular disease, and mortality: A meta-analysis. 2023; Article 1019534. https://doi.org/10.3389/fnut.2023.1019534
6. Yang Q, Zhang Z, Gregg EW, Flanders WD, Merritt R, Hu FB. Added Sugar Intake and Cardiovascular Diseases Mortality Among US Adults. JAMA Internal Medicine. 2014;174(4):516–524. https://doi.org/10.1001/jamainternmed.2013.13563
7. Lin J, Curhan GC. Associations of sugar and artificially sweetened soda with albuminuria and kidney function decline in women. Clinical Journal of the American Society of Nephrology. 2011;6(1):160–166. https://doi.org/10.2215/CJN.03260410
8. DiNicolantonio JJ, Lucan SC. The wrong white crystals: Not salt but sugar as aetiological in hypertension and cardiometabolic disease. Open Heart. 2014;1(1):e000167. https://doi.org/10.1136/openhrt-2014-000167